HIV patient care by clinic nurses rather than hospital doctors clinically successful, cost effective

July 19, 2011 in HIV & AIDS

Transferring care of HIV patients from doctors in hospitals to nurses in primary health clinics is both clinically successful and cost effective

Health outcomes for with HIV on antiretroviral (anti-HIV) 12 months after their care was transferred to a primary health clinic (a community clinic) where they were managed by nurses were equivalent, or even better, than the outcomes of similar patients on antiretroviral therapy who remained at a hospital-based, doctor-managed outpatient clinic.

Furthermore, the results of this study led by Lawrence Long from the University of the Witwatersrand in Johannesburg, South Africa, and published in this week's also show that this primary health care transfer strategy was cost effective and able to improve or maintain patient responses to antiretroviral therapy for 11% lower cost than doctor-managed, hospital-based outpatient treatment.

These findings are important as they suggest that this [primary-health-care transfer strategy] would increase treatment capacity, shift care from doctors to nurses (there are fewer doctors than nurses in South Africa), and conserve resources without compromising .

The authors of this study analyzed data collected from a group of over 700 with HIV initially treated by doctors at the Themba Lethu Clinic in Johannesburg and then transferred to a primary where nurses supervised their treatment. Each patient who transferred to the primary health care clinic was matched to three patients eligible for transfer but who remained in doctor-managed, hospital outpatient care and the and costs in the were compared one year after the transfer. All the patients in the study were doing well on treatment at the start of the one-year study period.

The authors found that only 1.7% of the transferred patients had died or had been lost to follow up compared to 6.2% of the patients who continued to receive doctor-managed, hospital-based antiretroviral therapy. The average cost per patient-year for those in care and responding at 12 months was US$492 for patients transferred to nurse-managed, primary care but US$551 for patients remaining in doctor-managed, hospital care. Additionally, the site spent US$509 per responsive patient, taking into account the costs of patients who were not in care and responding at 12 months, whereas the hospital spent US$602.

The authors say: "In addition to the financial cost savings estimated in this study, transferring patients to nurse-managed, primary-level clinics has the additional advantage of freeing up the time and resources of more highly trained doctors and well-equipped facilities to focus on patients who are not responding to treatment or have other complications."

They continue: "Task-shifting allows more health care workers to provide [antiretroviral therapy] care, and this in turn increases the treatment coverage available to meet the large unmet need."

In an accompanying Perspective, Nathan Ford from the medical humanitarian organization, Médecins Sans Frontières, and Ed Mills from the University of Ottowa in Canada (not involved in the research study) question how this study and other research can help to define future HIV programs, rather than validate what is already happening. They say: "We need to go much further. The ambition today is to provide [antiretroviral therapy] to many more people, and much earlier in their infection, over a long-term period. Realizing this ambition will depend on defining models of [antiretroviral therapy] delivery that are minimally intrusive to patient's lives."

Ford and Mills continue: "Several studies have demonstrated the feasibility of home-based and community-based [antiretroviral therapy] management, with positive results.

They conclude: "Future research on [antiretroviral therapy] delivery should build on these findings in order to help develop the elements that promote early HIV diagnosis, ensuring rapid enrolment into care, and support continuous adherence to an effective treatment regimen such that HIV care is largely a self-managed chronic disease, with the role of hospitals limited to providing care for a sick minority."

More information: Long L, Brennan A, Fox MP, Ndibongo B, Jaffray I, et al. (2011) Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort. PLoS Med 8(7): e1001055. doi:10.1371/journal.pmed.1001055

Provided by Public Library of Science search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created May 23, 2012 | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (1) | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

More mental health care urged for kids who self-harm

(HealthDay) -- Doctors have long known that some kids suffering severe emotional turmoil find relief in physical pain -- cutting or burning or sticking themselves with pins to achieve a form of release.

Neck strength, cervical spine mobility don't predict pain

(HealthDay) -- Neither isometric neck muscle strength nor passive mobility of the cervical spine, two physical capacity parameters found to be associated with neck pain in other studies, predicts later neck ...

In Spain, 70 percent of women use contraceptives during their first sexual encounter

Contraceptive use in Spain during the first sexual encounter is similar to other European countries. However, there are some geographical differences between Spanish regions: women in Murcia use contraceptives ...

World Health Assembly endorses new plan to increase global access to vaccines

Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to ...

P&G to add latches to make detergent packs safer

(AP) -- Procter & Gamble says it will change the design of packaging for its miniature laundry detergent product to deter children from eating the brightly colored packets that look like candy.